S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
Why Microsoft Just Placed A Huge Bet On Nuclear (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
Why Microsoft Just Placed A Huge Bet On Nuclear (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
Why Microsoft Just Placed A Huge Bet On Nuclear (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
The top-rated strong-buy stocks on Marketbeat’s radar
Why Microsoft Just Placed A Huge Bet On Nuclear (Ad)
Marketbeat’s AI-powered tools for investors
Are blue chip stocks a good investment?
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
As Dollar Tree Goes, So Goes the Consumer?
Power Play: GE's game-changing technology for EVs and grids
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Is Beyond an overlooked e-commerce winner?
Inflation in Europe falls to 2.4% as interest rates pack a punch. But the economy has stalled

Healthpeak Properties Stock Price, News & Analysis (NYSE:PEAK)

$17.32
+0.18 (+1.05%)
(As of 11/30/2023 ET)
Compare
Today's Range
$17.03
$17.45
50-Day Range
$15.55
$18.83
52-Week Range
$15.24
$28.43
Volume
9.79 million shs
Average Volume
4.56 million shs
Market Capitalization
$9.48 billion
P/E Ratio
39.36
Dividend Yield
6.93%
Price Target
$23.88

Healthpeak Properties MarketRank™ Stock Analysis

Analyst Rating
Hold
2.09 Rating Score
Upside/​Downside
37.8% Upside
$23.88 Price Target
Short Interest
Healthy
2.42% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.84
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
2.26%
From $1.77 to $1.81 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.70 out of 5 stars

Finance Sector

138th out of 857 stocks

Real Estate Investment Trusts Industry

22nd out of 176 stocks


PEAK stock logo

About Healthpeak Properties Stock (NYSE:PEAK)

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

PEAK Stock Price History

PEAK Stock News Headlines

Down 40% YTD, Can PEAK Stock Recoup Its Losses?
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Healthpeak Properties Inc's Dividend Analysis
Healthpeak Properties Inc PEAK
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
Healthpeak Properties earnings preview: what to expect
Healthpeak Properties: 7.2% Yielding SWAN
Is a Beat in Store for Healthpeak (PEAK) in Q3 Earnings?
Healthpeak Properties: A Safe 6.9% Yield
Scotiabank Keeps Their Hold Rating on Healthpeak Properties (PEAK)
See More Headlines
Receive PEAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Healthpeak Properties and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/30/2023
Ex-Dividend for 11/20 Dividend
11/06/2023
Dividend Payable
11/20/2023
Today
11/30/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/06/2024

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
N/A
Sector
Finance
Employees
199
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.88
High Stock Price Target
$32.00
Low Stock Price Target
$17.50
Potential Upside/Downside
+37.8%
Consensus Rating
Hold
Rating Score (0-4)
2.09
Research Coverage
11 Analysts

Profitability

Net Income
$500.45 million
Pretax Margin
12.29%

Debt

Sales & Book Value

Annual Sales
$2.06 billion
Cash Flow
$2.11 per share
Book Value
$12.77 per share

Miscellaneous

Free Float
546,035,000
Market Cap
$9.48 billion
Optionable
Optionable
Beta
0.98
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives















PEAK Stock Analysis - Frequently Asked Questions

Should I buy or sell Healthpeak Properties stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthpeak Properties in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" PEAK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PEAK, but not buy additional shares or sell existing shares.
View PEAK analyst ratings
or view top-rated stocks.

What is Healthpeak Properties' stock price target for 2024?

11 brokerages have issued 12 month price targets for Healthpeak Properties' stock. Their PEAK share price targets range from $17.50 to $32.00. On average, they expect the company's stock price to reach $23.88 in the next year. This suggests a possible upside of 37.8% from the stock's current price.
View analysts price targets for PEAK
or view top-rated stocks among Wall Street analysts.

How have PEAK shares performed in 2023?

Healthpeak Properties' stock was trading at $25.07 at the beginning of the year. Since then, PEAK stock has decreased by 30.9% and is now trading at $17.32.
View the best growth stocks for 2023 here
.

When is Healthpeak Properties' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 6th 2024.
View our PEAK earnings forecast
.

How were Healthpeak Properties' earnings last quarter?

Healthpeak Properties, Inc. (NYSE:PEAK) announced its earnings results on Monday, October, 30th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by $0.32. The firm had revenue of $556.20 million for the quarter, compared to analyst estimates of $543.57 million. Healthpeak Properties had a trailing twelve-month return on equity of 3.38% and a net margin of 11.17%. Healthpeak Properties's revenue was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.43 EPS.

How often does Healthpeak Properties pay dividends? What is the dividend yield for Healthpeak Properties?

Healthpeak Properties declared a quarterly dividend on Sunday, October 29th. Stockholders of record on Tuesday, November 7th will be given a dividend of $0.30 per share on Monday, November 20th. This represents a $1.20 dividend on an annualized basis and a yield of 6.93%. The ex-dividend date of this dividend is Monday, November 6th.
Read our dividend analysis for PEAK
.

Is Healthpeak Properties a good dividend stock?

Healthpeak Properties (NYSE:PEAK) pays an annual dividend of $1.20 per share and currently has a dividend yield of 7.05%. PEAK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 272.73%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, PEAK will have a dividend payout ratio of 66.30% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PEAK.

What guidance has Healthpeak Properties issued on next quarter's earnings?

Healthpeak Properties updated its FY 2023 earnings guidance on Monday, October, 30th. The company provided earnings per share guidance of $1.76-$1.78 for the period, compared to the consensus estimate of $1.76. The company issued revenue guidance of -.

What is Thomas M. Herzog's approval rating as Healthpeak Properties' CEO?

10 employees have rated Healthpeak Properties Chief Executive Officer Thomas M. Herzog on Glassdoor.com. Thomas M. Herzog has an approval rating of 100% among the company's employees. This puts Thomas M. Herzog in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Healthpeak Properties' major shareholders?

Healthpeak Properties' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Invesco Ltd. (4.41%), JPMorgan Chase & Co. (3.01%), Resolution Capital Ltd (2.13%), Northern Trust Corp (1.76%), Legal & General Group Plc (1.71%) and American Century Companies Inc. (1.65%). Insiders that own company stock include Christine Garvey, Sara Grootwassink Lewis, Scott M Brinker and Thomas Klaritch.
View institutional ownership trends
.

How do I buy shares of Healthpeak Properties?

Shares of PEAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:PEAK) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -